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ity in those patients who are in the lower 50th percentile forBody weight-for-height relationships predict mortality in main-
this measurement.tenance hemodialysis patients.
Background. Protein-energy malnutrition is a strong pre-
dictor of mortality in maintenance hemodialysis (MHD) pa-
tients. This association has generally been described for serum
Many epidemiological studies have shown a correla-chemistry measures of protein-energy malnutrition. We hy-
tion between parameters of protein-energy nutritionalpothesized that body weight-for-height relationships also pre-
dict survival in MHD patients. status and morbidity or mortality in maintenance dialysis
Methods. During the last three months of 1993, data were patients. These observations, in general, have demon-
obtained on 12,965 men and women concerning clinical charac- strated relationships between serum chemistry measures,teristics (height, postdialysis weight, age, gender, race, and
dietary protein intake as indicated by the protein equiva-presence or absence of diabetes mellitus) and laboratory mea-
lent of protein nitrogen appearance (PNA, also calledsurements (predialysis serum albumin, creatinine and choles-
terol, and the urea reduction ratio). Patient survival during the PCR), postdialysis body weight, and clinical outcome
next 12 months was evaluated retrospectively. [1–6]. In maintenance hemodialysis (MHD) patients, the
Results. In comparison to values for normal Americans de- serum chemistry measurements which reflect nutritionaltermined from the National Health and Nutrition Evaluation
status or nutrient intake and which correlate with mor-Survey II data, weight-for-height relationships tended to be
bidity or mortality include predialysis serum albumin,slightly lower than normal in African American men and
women and Caucasian men undergoing MHD and were normal creatinine, urea, cholesterol, potassium, and phosphorus
or slightly greater in the taller Caucasian women. In both men [1, 2, 4, 5].
and women, the mortality rate decreased progressively as the These relationships may be particularly important forpatients’ weight-for-height increased. MHD patients who
the following reasons: (a) Some of these nutritional pa-weighed more than normal had the lowest mortality rates.
rameters, such as the serum albumin, strongly predictAfter adjustment for clinical characteristics and laboratory
measurements, the inverse relationship between mortality rates outcome [2, 4, 5]. (b) Many MHD patients have evidence
and weight-for-height percentiles was still highly significant for of protein-energy malnutrition [1–7]. (c) The mortality
patients within the lower 50th percentile of body weight-for- rate of MHD patients is very high [2, 4, 5, 8], averaging
height. Serum albumin correlated directly with weight-for-height
over 20% in the United States. (d) Certain nutritionalin patients in the lower 50th percentile of weight-for-height.
parameters are potentially modifiable, and there is aSerum creatinine and cholesterol correlated directly with
weight-for-height in the entire population of men and women. possibility that altering these nutritional parameters may
In contrast, the urea reduction ratio was inversely correlated improve outcome; this possibility has not yet been tested
with weight-for-height. in randomized prospective clinical trials.Conclusions. These data indicate that weight-for-height is a
Because body weight-for-height relationships predictstrong predictor of 12-month mortality in male and female
clinical outcome in healthy men and women [9–11], weMHD patients. Multivariate analyses indicate that body
weight-for-height is an independent predictor of higher mortal- assessed the relationship of weight-for-height to mortal-
ity in a retrospective analysis of data obtained from
12,965 MHD patients. Four primary questions were ad-
Key words: protein-energy malnutrition, survival rate for hemodialysis,
dressed: (a) How does the distribution of weight-for-dialysis, albumin, creatinine, cholesterol, mortality prediction, mainte-
nance hemodialysis. height and body mass index (BMI) in MHD patients
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nutritional and clinical measures? (d) Is there an optimal Weight-for-height distributions were developed by
classifying males and females separately into groups ac-or desirable range of weights-for-height that is associated
with an increased probability of survival? cording to their height clustered in 3 cm integers. The
percentiles for weight within each height range were
determined separately for each gender and are referred
METHODS
to as “weight-for-height percentiles.”
Data from 12,965 patients were extracted from the No adjustments of body weight were made for ampu-
Fresenius Medical Care NA Patient Statistical Profile tations because accurate data on the number of amputa-
System database. The database has been described pre- tions or extent of any amputations were not available.
viously [12, 13]. Patients who had been receiving MHD We estimate that no more than 5 to 10% of dialysis
treatment three times weekly on January 1, 1994, and patients had amputations. Because roughly 40% of
who either lived the following 12 months while undergo- the patients were diabetic, approximately 2 to 4% of
ing MHD or died during that year were selected for the the patients may have had amputations. Many of the
initial sample. Individuals who received a renal trans- amputations would involve toes, a foot, or a leg below
plant, transferred to a different dialysis modality (for the knee. Thus, in this small subset (2 to 4%) of patients
example, peritoneal dialysis), or were lost to follow-up who might be expected to have amputations, the impact
were excluded from all of the analyses. Patients’ files on their body weight-for-height relationships could be
were examined for values from laboratory tests per- considered to be usually small. The effect of the amputa-
formed after a three-day interdialytic interval during the tions on the relationship between weight-for-height and
last three months of 1993. These tests included the predi- 12-month mortality for the entire cohort of patients in
alysis serum concentrations of albumin, creatinine, cho- this study, hence, could be considered to be rather min-
lesterol, alkaline phosphatase, anion gap, bilirubin, and imal.
the urea reduction ratio (URR). Clinical files were exam-
ined for the values for height, postdialysis weight, age, Statistical analyses
gender, race, and the presence or absence of diabetes Crude mortality rates among males and females
mellitus. The laboratory data and postdialysis weights grouped by weight-for-height percentile were evaluated
were averaged for the three-month period. These values, using a chi-square test [16]. The chi-square statistic was
as well as the previously indicated patient characteristics, partitioned into components reflecting a linear or or-
were merged with the survival data. Only patients in dered effect (x2L) and a residual or nonordered effect
whom values for each of these variables were obtained (x2R) [16]. The odds ratios for death were also evaluated
were accepted for analysis. using logistic regression analysis [17]. Possible differ-
Determination of race was based on the patients’ an- ences of selected nutrition-related measures (predialysis
swer to the question of whether they were Caucasian, serum albumin, creatinine, and cholesterol) and dialysis
African American, or Other. When the data were ana- dose (the URR) among patients grouped by weight-for-
lyzed according to whether the patients were Caucasian height percentiles were evaluated by analysis of variance.
or African American, only those individuals who had Finally, possible differences for weight-for-height and
categorized themselves as such were included in these BMI between the MHD patients and the general U.S.
analyses. All laboratory measurements were performed population were evaluated using graphic techniques
in a single laboratory (LifeChem Clinical Laboratories, (that is, by examining the shapes of the scatter-plots).
Rockleigh, NJ, USA). Tests were performed on Hitachi Analysis of variance was performed in selected cases;
Model 736-50 and 747-200 analyzers using conventional the partitioned sums of squared deviations for the U.S.
methods and reagents (Boehringer Mannheim Co. CP, population groups were estimated from the NHANES
Indianapolis, IN, USA). The URR was calculated as the II data [15].
percentage fall of serum urea nitrogen (SUN) during the
dialysis treatment. The BMI was computed as the ratio
RESULTSof the postdialysis body weight (kg) to the square of the
patient’s height (meters). Body surface area (BSA) was Some characteristics of the 12,965 patients are shown
in Table 1. In general, the characteristics of the patientsestimated by the equation of Dubois and Dubois [14].
The patients’ weights were compared with weights of are similar to the total U.S. MHD population as reported
by the United States Renal Data System [8]. The meannormal people of the same height, gender, and age range.
The values for these normal weights were obtained from age of the entire group was 60.3 years. A portion (50.2%)
of the patients were male, while 47.7% of the patientsthe National Health and Nutrition Evaluation Survey
(NHANES) II database for age, sex, and height, as re- listed themselves as Caucasian, and 52.3% of patients
described themselves as African American. Diabetesported by Frisancho [15]; the tables used were not ad-
justed for skeletal frame size. mellitus, which was more common in the women, was
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Table 1. Characteristics of subjects
Males (N 5 6,504) Females (N 5 6,461)
Variable Mean sd Median Mean sd Median
Age years 59.1 15.4 60.9 61.5 14.3 64.0
Race % Caucasian 50.1 N/A N/A 45.3 N/A N/A
Diabetes mellitus % of patients 33.7 N/A N/A 46.0 N/A N/A
Body weight kg 73.8 17.0 71.0 65.9 17.4 62.7
Body mass index kg/m2 24.4 5.2 23.6 25.4 6.4 24.3
Body surface area m2 1.9 0.2 1.9 1.7 0.2 1.7
Serum or blood
Albumin g/dl 3.9 0.4 3.9 3.8 0.4 3.8
Creatinine mg/dl 11.8 3.8 11.5 9.8 2.9 9.6
Cholesterol mg/dl 166 41 162 186 46 183
Calcium mg/dl 9.1 0.9 9.1 9.2 0.9 9.2
Phosphorus mg/dl 6.1 1.8 6.0 6.1 1.8 5.9
LDH l/liter 205 60 194 212 64 201
Bilirubin mg/dl 0.6 0.3 0.5 0.5 0.4 0.5
Alkaline phosphatase, l/liter 135 134 100 151 152 111
Hemoglobin g/dl 9.9 1.4 9.9 9.6 1.2 9.6
Iron lg/dl 54.4 25.4 50.3 52.5 25.0 48.0
Ferritin ng/ml 278 411 169 320 470 195
Anion gap mEq/liter 22.2 4.0 22.2 21.9 3.9 21.8
Abbreviations are: N, number of patients; sd, standard deviation; N/A, not applicable.
present in 39.3% of the patients. The mean and median mortality rates in men in the 50th to 75th percentiles as
compared with those in the 75th to 90th percentiles, butduration of dialysis therapy was 3.75 and 2.50 years,
those with weights-for-height in the latter percentilesrespectively.
had significantly higher death rates than those in the
Weight-for-height percentiles and mortality rates greater than 90th percentile range (P 5 0.032). The over-
all statistics show a statistically significant trend for aThe distribution of weight-for-height percentiles is
shown in Table 2. The format is similar to that reported decreasing odds ratio of death with increasing weight-
for-height percentiles (x2L 5 104.1, P , 0.001). The sig-by Frisancho using the NHANES data from normal indi-
viduals [15]. The crude mortality rates for men and nificant residual effects (x2R) are due to the slight but
not significant increase in death rate in the 75th to 90thwomen, grouped by weight-for-height percentiles, are
shown in Figure 1. The chi-square statistics for a linear percentile group as compared with the 50th to 75th per-
centile cohort.trend and residual effect are given in the figure legend.
The values at the lower part of each bar are P values The pattern among women was, in general, similar
(Fig. 1B). The women also displayed a significant linearthat indicate the statistical probability of no difference
from the next higher percentile. In men and women trend for improving death risk with increasing weight-
for-height percentiles (x2L 5 59.3, P , 0.001), but withoutconsidered separately, there was a significantly increased
death rate in individuals who had weights-for-height in significant residual effects (x2R 5 5.6, P 5 NS). Although
there were no statistically significant differences in thethe lower 50th percentile as compared with the upper
50th percentile. Moreover, there was a clear trend for 12-month death rate among the three highest percentile
groups, there appeared to be a downward trend in theprogressively increasing death rates as the weight-for-
height percentile values decreased below the 50th per- odds ratio for death as the weight-for-height percentiles
increased.centile.
In Figure 1A, the P value of ,0.001 at the lower part Table 3 shows the results of the logistic regression
analyses for males and females. Values are listed sepa-of the left-most bar (that is, weight-for-height percen-
tile # 10) indicates that the death rate among those rately for demographic or clinical variables (age, race,
presence or absence of diabetes mellitus), characteristicspatients was significantly greater (P , 0.001) as com-
pared with men with weights-for-height in the 10th to related to protein-energy nutritional status (predialysis
serum albumin and creatinine, weight-for-height percen-25th percentile. Similarly, men with the latter weight-
for-height percentiles had a significantly higher death tile), and other laboratory measures. It is recognized that
many of the measures in the “other laboratory value”rate as compared with the men in the 25th to 50th percen-
tile. These latter individuals, in turn, had a significantly group also may be influenced by nutrition-related fac-
tors. The measures within each grouping of variableshigher mortality rate than those in the 50th to 75th per-
centile. There was no significant difference between the (demographic, nutrition-related, and other laboratory)
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Table 2. Weight (kg): Means, standard deviations and percentiles by height (cm)
Weight percentiles
Height (cm) N Mean sd 5th 10th 15th 25th 50th 75th 85th 90th 95th
Males
,153 145 59.9 17.0 43.0 45.0 46.0 49.0 58.0 66.0 71.0 76.0 88.0
156–158 194 63.2 13.8 45.0 49.0 51.0 54.0 60.0 70.0 75.0 80.0 95.0
159–161 161 63.9 17.2 45.0 49.0 51.0 55.0 61.0 68.0 73.0 81.0 96.0
162–164 291 65.0 13.2 47.0 51.0 54.0 56.0 63.0 71.0 76.0 81.0 90.0
165–167 421 65.4 13.2 49.0 52.0 54.0 57.0 64.0 71.0 76.0 81.0 89.0
168–170 639 68.5 13.8 49.0 53.0 56.0 59.0 66.0 75.0 82.0 87.0 93.0
171–173 610 70.8 13.6 53.0 56.0 58.0 62.0 69.0 78.0 83.0 87.0 95.0
174–176 1379 73.3 15.2 55.0 58.0 60.0 63.0 71.0 80.0 86.0 91.0 98.0
177–179 683 77.6 17.2 57.0 60.0 63.0 67.0 75.0 85.0 91.0 97.0 108.0
180–182 562 77.0 15.2 57.0 60.0 63.0 67.0 74.0 85.0 92.0 97.0 108.0
183–185 499 80.9 18.5 59.0 62.0 65.0 68.0 77.0 88.0 96.0 105.0 119.0
186–188 307 83.6 17.5 61.0 66.0 69.0 72.0 81.0 91.0 99.0 105.0 116.0
189–191 270 85.9 20.4 62.0 66.0 68.0 73.0 82.5 93.0 101.0 110.0 129.0
192–194 203 87.2 21.6 61.0 65.0 68.0 72.0 82.0 99.0 110.0 119.0 127.0
Females
,141 58 53.6 15.1 32.0 36.0 38.0 42.0 51.5 61.0 70.0 73.0 84.0
141–143 44 53.5 11.0 40.0 41.0 42.0 45.0 52.0 60.0 62.0 64.0 77.0
144–146 72 51.8 12.0 36.0 40.0 41.0 44.5 49.0 56.5 61.0 64.0 86.0
147–149 82 53.8 15.0 40.0 41.0 42.0 45.0 50.0 59.0 64.0 71.0 84.0
150–152 192 58.4 15.0 38.0 41.0 44.0 48.0 57.0 65.5 73.0 77.0 82.0
153–155 591 58.9 15.4 40.0 42.0 44.0 48.0 56.0 67.0 73.0 80.0 91.0
156–158 1379 62.1 15.4 42.0 45.0 47.0 51.0 60.0 70.0 77.0 84.0 92.0
159–161 812 64.9 15.6 45.0 47.0 50.0 53.0 62.0 74.0 80.0 86.0 93.0
162–164 908 66.9 16.8 45.0 49.0 51.0 55.0 64.0 76.0 83.0 88.0 98.0
165–167 679 68.3 17.2 47.0 50.0 53.0 56.0 65.0 78.0 84.0 91.0 102.0
168–170 639 70.0 17.4 47.0 51.0 53.0 57.0 67.0 80.0 88.0 94.0 102.0
171–173 369 72.9 18.1 49.0 53.0 55.0 60.0 71.0 83.0 90.0 95.0 110.0
174–176 338 76.0 19.8 50.0 55.0 57.0 61.0 73.0 86.0 95.0 102.0 110.0
177–179 52 80.8 19.8 53.0 58.0 61.0 68.0 80.0 91.0 98.0 105.0 111.0
.179 107 82.3 26.7 52.0 58.0 61.0 65.0 78.0 93.0 98.0 119.0 128.0
are listed in order of decreasing strength for their associa- measures. After such adjustments, the statistical signifi-
cance of the reduced odds ratio of death in the patientstion with the odds ratio of death as judged by the x2
value. in the greater than 90th percentile as compared with the
reference group (75th to 90th percentile) disappeared.Age and the predialysis serum albumin and creatinine
concentrations were the three variables most strongly However, with or without the foregoing adjustments, the
patients in all of the weight-for-height percentiles belowassociated with odds of death. Advancing age was associ-
ated with increasing odds of death, whereas increasing 50% had increased odds ratios for death. Moreover, with
or without these adjustments, the overall reduction inserum albumin or creatinine concentrations were associ-
the odds ratio for death with increasing weight-for-heightated with decreasing odds ratios. Greater weight-for-
was statistically significant (x2 males 5 23.4, P , 0.001;height percentiles also were associated with falling odds
x2 females 5 25.1, P , 0.001).of death. The odds ratios were similar in both genders.
Indeed, the odds ratios (0.993) and 95% confidence inter-
Relationship between laboratory measurements ofvals for weight-for-height were identical in men and
nutritional status or dialysis dose and weight-for-women.
height percentilesFigure 2 shows the relationship between the odds ratio
for death and the weight-for-height percentiles in men Figure 3 shows the mean values for the protein-energy
nutrition-related laboratory measures in each of theand women combined under three conditions: unad-
justed; adjusted for age, gender, race, and diabetes melli- weight-for-height percentile groups. Analysis of variance
was performed, and a priori planned intergroup compari-tus; and adjusted both for these case mix characteristics
and for all of the laboratory measures indicated in Table sons were made. The values at the top of each bar indi-
cated the significance of difference from a reference3. There appeared to be a nearly monotonic improve-
ment of death odds with increasing weight-for-height (“Ref”) group determined as the values for patients at
the 50th to 75th percentile for weight-for-height. The Pprior to adjustment for case mix and case mix plus other
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Fig. 1. Crude mortality rates among males (A) and females (B) grouped by weight-for-height percentiles. The linear and residual x2 statistics for
the entire set of data in males and females, considered separately, are: males x2L 5 104.1, P , 0.001, and x2R 5 27.1, P , 0.001; females x2L 5
59.3, P , 0.001, and x2R 5 5.6, P 5 NS. The P values at the bottom of each bar indicate the significance of differences in the death rate between
that height-for-weight percentile and the next higher height-for-weight percentile.
value at the base of each bar indicates the significance percentile groups had the highest URR values. It follows
from these observations that patients with the lowestof difference from the next higher weight-for-height per-
predialysis serum albumin, creatinine, and cholesterolcentile group.
concentrations and highest URR values had not only theFigure 3A indicates the highly significant difference
lowest weight-for-height percentiles but also the highestamong the weight-for-height percentile groups with re-
odds ratios of death during the 12-month period follow-gard to the mean predialysis serum albumin levels. All
ing these measurements.of the groups below the 50th percentile had significantly
lower serum albumin concentrations as compared with
Body size in maintenance hemodialysis patients versusthe groups in the 50th to 75th percentile or higher. Fur-
the general U.S. population
thermore, each weight-for-height group below the 50th
The anthropometric measures of weight-for-heightto 75th percentile had a lower mean serum albumin con-
and BMI of the MHD patients were compared withcentration than the next higher percentile group.
similar measurements obtained for the general U.S. pop-Figure 3B shows these relationships for the mean pre-
ulation in the NHANES Study (Figs. 4, 5, and 6) [15].dialysis serum creatinine concentrations. There was a
Among all men combined, body weight was greater atmonotonic lowering of serum creatinine concentrations
all height groupings in the normal individuals as com-as the weight-for-height percentiles decreased from the
pared with the MHD patients (Fig. 4). The weight differ-
.90th percentile to the #10th percentile. With each ences between these two groups appear somewhat
weight-for-height percentile below the reference range, greater at taller heights and account for a statistical inter-
the serum creatinine was significantly lower than in the action between height and subject groups (that is, MHD
next higher percentile group. On the other hand, the vs. normal individuals).
serum creatinine was highest in the patients in the greater Among females, the shorter MHD patients weighed
than 90th weight-for-height percentile. Similarly, Figure less than normal individuals (Fig. 4). The curves crossed
3C demonstrates a clear monotonic reduction in serum over in the mid-height ranges so that taller female MHD
cholesterol concentrations with decreasing weight-for- patients appeared to be slightly heavier than their normal
height percentile groups. counterparts. Analysis of variance revealed a barely sig-
Figure 3D shows that there was clear monotonic in- nificant difference between MHD patients and normal
crease in the URR with declining weight-for-height per- individuals, but the interaction between height and sub-
ject groups was significant, reflecting the crossover effect.centiles. Those patients in the lowest weight-for-height
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Table 3. Logistic regression of odds ratio of death on variables during 1994
Variable x2 P OR 95% CI
Males
Demographic
Age years 125.6 ,0.001 1.034 1.028–1.040
Race (Ref 5 non-white) 0.2 NS 0.961 0.821–1.125
Diabetes (Ref 5 non-diabetic) 1.3 NS 1.094 0.938–1.276
Nutrition-related
Serum albumin g/dl 103.9 ,0.001 0.330 0.266–0.408
Serum creatinine mg/dl 86.9 ,0.001 0.868 0.842–0.894
Weight-for-height percentile % 23.4 ,0.001 0.993 0.991–0.996
Serum cholesterol mg/dl 13.4 ,0.001 0.997 0.995–0.998
Other laboratory valuesa
Serum calcium mg/dl 40.0 ,0.001 1.342 1.225–1.470
Serum anion gap mEq/liter 32.1 ,0.001 1.069 1.045–1.094
Serum phosphorus mg/dl 32.1 ,0.001 1.151 1.097–1.209
Serum LDH l/liter 28.0 ,0.001 1.003 1.002–1.005
Blood hemoglobin g/dl 23.9 ,0.001 0.861 0.881–0.914
Urea reduction ratio % 9.1 0.003 0.986 0.977–0.995
Serum bilirubin mg/dl 7.7 0.006 1.515 1.130–2.031
Serum alkaline phosphatase l/liter 6.2 0.013 1.001 1.000–1.001
Serum ferritin ng/ml 2.0 NS 1.000 1.000–1.000
Serum iron mg/dl 1.4 NS 0.998 0.995–1.001
Females
Demographic
Age years 111.2 ,0.001 1.032 1.026–1.038
Race (Ref 5 non-white) 7.0 0.008 1.220 1.053–1.141
Diabetes (Ref 5 non-diabetic) 15.8 ,0.001 1.345 1.162–1.558
Nutrition-related
Serum albumin g/dl 61.6 ,0.001 0.425 0.344–0.527
Serum creatinine mg/dl 51.3 ,0.001 0.883 0.853–0.914
Weight-for-height percentile % 25.1 ,0.001 0.993 0.991–0.996
Serum cholesterol mg/dl 10.2 0.02 0.997 0.996–0.999
Other laboratory valuesa
Serum calcium mg/dl 17.3 ,0.001 1.207 1.105–1.319
Serum anion gap mEq/liter 43.2 ,0.001 1.069 1.045–1.094
Serum phosphorus mg/dl 5.5 0.019 1.058 1.009–1.109
Serum LDH l/liter 44.1 ,0.001 1.004 1.003–1.005
Blood hemoglobin g/dl 20.4 ,0.001 0.865 0.813–0.921
Urea reduction ratio % 32.9 ,0.001 0.975 0.966–0.983
Serum bilirubin mg/dl 11.1 ,0.001 1.820 1.279–2.590
Serum alkaline phosphatase l/liter 8.8 0.003 1.001 1.000–1.001
Serum ferritin ng/ml 9.0 0.003 1.000 1.000–1.000
Serum iron mg/dl 2.7 0.099 0.997 0.994–1.000
Abbreviations are: x2, the Chi-square statistic; P, probability of HO; OR, the odds ratio for death; 95% CI, the 95% confidence interval of the OR; NS, not
significant.
a It is recognized that many of the measures in the “other laboratory value” group also may be influenced by nutrition-related factors; the coefficient b 5 2 0.00654 6
0.00135 se.
Figure 5 compares the weight-for-height distributions 6. The BMI of normal African American females 25 to
30 years of age or older was greater than that of normalby gender and race, limiting the sample to African Amer-
ican and Caucasian persons. The crossover effect is most African American men or Caucasian males or females.
The BMI of young normal white females was lower thanapparent among Caucasian females. In contrast, the
greatest difference between the weight-for-height ratios any of the other three groups of normal individuals. The
BMI of normal African American men was similar toof MHD patients as compared with normal individuals
was observed for Caucasian men. For a given height, that of Caucasian men.
The BMI for female African American MHD patientsfemale African American MHD patients and normal
female African Americans each weighed more than their was higher than the BMI of the other three groups of
MHD patients (Fig. 6). In general, the BMI of the Cauca-Caucasian female counterparts. This relationship was not
apparent for men. sian male and female MHD patients and of African
American male MHD patients did not differ. For mostThe BMI of the MHD patients and normal individuals
is shown for Caucasians and African Americans in Figure age groups in African American men and women and
Kopple et al: Mortality in MHD patients1142
Fig. 2. Odds ratio of death among patients
grouped by weight-for-height percentiles. Three
representations are given in each cluster of
three bars. Symbols are: (j) unadjusted odds
ratio; (h) odds ratio adjusted for clinical
characteristic variables (age, gender, race,
diabetes mellitus); ( ) adjusted for clinical
characteristics and laboratory variables (pre-
dialysis serum albumin, creatinine, and cho-
lesterol and the urea reduction ratio). The
P values symbols over a bar indicate the sig-
nificant difference between the values for that
bar and for the reference group. *P , 0.001;
**P 5 0.11; † P 5 0.21; # P 5 0.038.
Fig. 3. Predialysis serum albumin (A), creatinine (B), and cholesterol (C) concentrations and the urea reduction ratio (URR; D) for each weight-
for-height percentile group. The P values at the base of the bars indicate the statistical difference between the serum chemistry or URR of patients
at that weight-for-height percentile and the next higher percentile group. The P values over the bars indicate the statistical difference between
the values for that group and the reference group (Ref). The relationship between the laboratory variables and the weight-for-height percentile
was significant for the predialysis serum albumin (F 5 42.3, P , 0.001), creatinine (F 5 140.1, P , 0.001), and cholesterol (F 5 57.7, P , 0.001)
and for the urea reduction ratio (F 5 110.7, P , 0.007).
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Fig. 4. Distributions of weights-for-height
among normal men and women in the United
States as obtained from the NHANES data
(j) and male and female maintenance hemo-
dialysis (MHD) patients from our study ( ).
F tests in males were: height 5 292 (P , 0.001);
MHD vs. Normal 5 240 (P , 0.001); interac-
tion 5 3 (P , 0.01). F tests in females were:
height 5 101 (P , 0.001); MHD vs. Nor-
mal 5 5 (P , 0.05); Interaction 4 (P , 0.001).
Caucasian men, the BMI was lower in the MHD patients ship between their body mass adjusted for height and
as compared with normal individuals (Fig. 6). This rela- their risk of death. This relationship was observed in
tionship appeared to be most striking for the African almost 13,000 patients in whom a nutritional assessment
American women who were in the 25- to 30-year age was performed and their survival was evaluated over a
bracket or older. In Caucasian women, the BMI in the subsequent 12-month period. The relationship between
MHD patients as compared with normal individuals was low body weight and increased mortality was particularly
more variable. striking for patients in the lower 50th percentiles of
weight-for-height values. However, there was a statisti-
DISCUSSION cally downward trend in mortality as body weight-for-
height increased from the lower 10th percentile toThe results of this study indicate that in men and
women undergoing MHD, there is an inverse relation- greater than the 90th percentile (Figs. 1 and 2). Part of
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Fig. 5. Distributions of weight-for-height among normal individuals in the United States from the NHANES data (j) and for the maintenance
hemodialysis (MHD) patients ( ). Data are arrayed by race and gender.
the strength of this relationship can be accounted for by was observed for all statures of men (that is, for heights
of 156 to 194 cm) and for shorter women (that is, heightsthe case mix variables (that is, age, gender, race, and
diabetes mellitus) and the laboratory measures indicated of 156 to 158 cm or lower; Fig. 4). The smaller weights-
for-height or BMIs in the MHD patients were particu-in Table 3. Even after adjusting for the case mix with
or without these laboratory measures, there was still larly evident for African American men and women and
Caucasian men (Figs. 5 and 6). The lower weight-for-progressively increasing mortality rate as body weight-
for-height values decreased, but this rising mortality was height values in the MHD patients were almost always
within 10% of the values for normal adults as obtainedonly significant for patients in the lower 50th percentile
of weight-for-height values (Fig. 2). These findings indi- from the NHANES II data (Figs. 4 and 5).
The NHANES data indicate that the body mass indi-cate that body mass, independent of these other nutri-
tional measures, is a predictor of 12-month mortality in ces of normal Americans increased by an average of 4%,
and the prevalence of overweight rose by 8% betweenMHD patients.
The weight-for-height values or body mass indices of the time of collection of the NHANES II data (1976 to
1980) and the collection of the NHANES III data (1988the patients tended to be slightly lower than those of
normal men and women as determined from the to 1991) [18]. At the time that the data from the present
study were analyzed, the values from NHANES III wereNHANES II data (Figs. 4, 5, and 6). This relationship
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Fig. 6. Body mass index (BMI) arrayed by age for normal individuals in the United States from the NHANES data (j) and for the maintenance
hemodialysis (MHD) patients ( ). Data are categorized according to race and gender.
not readily available for comparison. Thus, the body direct relationship between the odds ratio of death and
measures that reflected either nutrient intake (that is,weights of the MHD patients, which were obtained in
1993, were compared with body weights collected from predialysis serum urea, creatinine, cholesterol, potas-
sium, and phosphorus and the anion gap) or body proteinnormal individuals from 1976 to 1980 (NHANES II). It
is likely that the body weights of the MHD patients, in or muscle mass (that is, predialysis serum albumin, preal-
bumin, and creatinine) [1–6]. In this study, the predialysiscomparison to normal individuals, would be somewhat
smaller if the MHD patients were compared with normal serum albumin, creatinine, and cholesterol values in-
creased as the weight-for-height values rose (Fig. 3 A–C);Americans who were evaluated at the same time as the
MHD patients. Nonetheless, because the mean body this relationship was observed for the lower 50th percen-
tile of weights-for-height (Fig. 3A), if not for the entireweights-for-height of the MHD patients were, at most,
not much lower than normal values and because unad- range of weights-for-height (Fig. 3 B, C). Because the
weights-for-height also correlated inversely with thejusted mortality rates decreased as weights-for-height
rose to greater than the 90th percentile in the MHD death rate, these findings are consistent with the previous
reports of the correlation of predialysis serum albumin,patients (Fig. 1), it follows that even in MHD patients
who have normal or greater than normal body weights creatinine, and cholesterol with survival rates in MHD
patients.for a given height, the mortality rates decreased as
weights-for-height increased. The finding that the URR decreased as the weight-
for-height ratios rose (Fig. 3D) may reflect the fact thatPrevious studies in MHD patients have indicated a
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Fig. 7. Relationship between postdialysis body
weight, body height, and the odds ratio (OR)
of death during a 12-month period in men
undergoing maintenance hemodialysis. Each
OR is in reference to the range of weight-for-
height values between two adjacent percentile
bars. The P values indicate the probability of
no statistical difference for a given odds ratio
as compared with the reference odds ratio.
for a given dose of hemodialysis, the smaller the patient’s man et al, J Am Soc Nephrol 9:208A, 1998) [21, 22]. The
reason for the discrepancy between these findings inbody mass, and hence, urea compartment, the greater
will be the reduction in the URR. The data also support MHD patients and the observations in normal individu-
als is not clear.several studies that suggest that within the range of he-
modialysis doses currently used, the URR or Kt/V In this study, MHD patients with low weight-for-
height values may have been more likely to have chronic,(which correlates with the URR) is not a powerful pre-
dictor of survival in MHD patients [19, 20]. Indeed, it is life-threatening, underlying illnesses (for example, se-
vere heart failure and chronic obstructive pulmonarypossible that one cause of the low correlation between
the URR or Kt/V and survival in MHD patients is that disease) that engender malnutrition by causing anorexia
and by catabolic stimuli. In these circumstances, thethe URR or Kt/V not only reflects the rate of removal
of urea during a hemodialysis treatment but also that it cause of death may be totally or partially independent
of malnutrition. Other factors, such as increased in-is inversely related to body mass (Figure 3D); the body
mass, as we have shown, is directly correlated with mor- flammatory cytokine and counter-regulatory hormone
levels or tissue hypoxia, may contribute to reduced bodytality rates in MHD patients. It is also likely that the
trend toward higher URR values and perhaps a more mass in chronically ill MHD patients who are at in-
creased risk for death [23]. It is possible that such cata-narrow range of URR in MHD patients in recent years
may have diminished the strength of the relationship bolic illnesses may not only decrease body mass, but also
cause depletion of other biologically valuable com-between URR and mortality in this study.
A number of studies indicate that normal individuals pounds. It has recently been hypothesized that certain
inflammatory cytokines may stimulate atherosclerosiswith increased body mass, as indicated by a greater BMI
or weight-for-height value, have higher mortality [9–11]. and proliferation of the intimal cells in the coronary
arteries or other blood vessels, thereby increasing theThese observations stand in direct contrast to the find-
ings from this study. Other investigators have also re- risk for myocardial infarction or other vascular events
[24]. It may be pertinent that some but not all studiesported that low body mass indices are associated with
increased mortality in MHD patients (abstract; Fleisch- indicate that in older normal men and women who pre-
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Fig. 8. Relationship between postdialysis body
weight, body height, and the odds ratio (OR)
of death during a 12-month period in women
undergoing maintenance hemodialysis. Each
OR is in reference to the range of weight-for-
height values between two adjacent percentile
bars. The P values indicate the probability of
no statistical difference for a given odds ratio
as compared with the reference odds ratio.
sumably may have acquired more chronic illnesses than It is also pertinent that among the MHD patients who
were in the higher 50th percentile for body weight-for-younger adults, a greater BMI is less strongly associated
with higher mortality [25, 26]. height, there was a trend, often significant, for mortality
to fall as body-for-weight increased. Much of this correla-Another possible explanation for these findings is that
MHD patients who have low weight-for-height values tion can be accounted for by covariant factors (Fig. 2).
Nonetheless, from the perspective of the clinician, thesetolerate chronic renal failure or uremia less well.
Whether this might be due to a more severe form of the data indicate that those MHD patients who have the
greatest weight-for-height values do, in fact, have apolyendocrinopathy that occurs in chronic renal failure
[27], greater levels or increased sensitivity to uremic tox- greater 12-month survival.
A nomogram describing the relationship betweenins [28], or other disorders associated with chronic renal
failure or maintenance dialysis treatment is unclear. postdialysis body weight, height, and the odds ratios for
12-month mortality in the men and women in this studyWhatever is the cause for this association, the fact re-
mains that this research as well as other studies (abstract; is shown in Figures 7 and 8. It is apparent that for a
given height, there is a downward trend in mortality asibid) [21, 22] indicate that a low body weight-for-height
increases mortality in MHD patients. The causes for this the postdialysis body weight increases. Figures 7 and 8
may be used to estimate the prognosis of an MHD pa-relationship would seem to be an important area for
further research. tient. These data also raise the intriguing question as to
whether an increase in a patient’s weight-for-height toIn some studies of normal adults, a “J” or “U” curve
effect was observed in which those individuals with a a level associated with a lower odds ratio of death will
reduce the patient’s probability of dying. If we assumelow BMI had an increased mortality [10, 11, 29]. This
“J” or “U” curve effect may disappear when the data that an increase in an MHD patient’s weight will enhance
his/her probability of survival, then these nomogramsare adjusted for nonsmokers [11]. In this study, we did
not evaluate the effect of smoking on the relationship may be used to develop strategies to enhance the pa-
tient’s health and probability of survival. Because mor-between weights-for-height and mortality in MHD pa-
tients. tality rates of MHD patients are approximately 22% per
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